Suppr超能文献

用于癌症治疗的谷胱甘肽响应型单宁酸辅助荧光共振能量转移纳米药物

Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy.

作者信息

Laskar Partha, Dhasmana Anupam, Kotnala Sudhir, Jaggi Meena, Yallapu Murali M, Chauhan Subhash C

机构信息

Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA.

South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA.

出版信息

Pharmaceutics. 2023 Apr 24;15(5):1326. doi: 10.3390/pharmaceutics15051326.

Abstract

In cancer combination therapy, a multimodal delivery vector is used to improve the bioavailability of multiple anti-cancer hydrophobic drugs. Further, targeted delivery of therapeutics along with simultaneous monitoring of the drug release at the tumor site without normal organ toxicity is an emerging and effective strategy for cancer treatment. However, the lack of a smart nano-delivery system limits the application of this therapeutic strategy. To overcome this issue, a PEGylated dual drug, conjugated amphiphilic polymer (CPT-S-S-PEG-CUR), has been successfully synthesized by conjugating two hydrophobic fluorescent anti-cancer drugs, curcumin (CUR) and camptothecin (CPT), through an ester and a redox-sensitive disulfide (-S-S-) linkage, respectively, with a PEG chain via in situ two-step reactions. CPT-S-S-PEG-CUR is spontaneously self-assembled in the presence of tannic acid (TA, a physical crosslinker) into anionic, comparatively smaller-sized (~100 nm), stable nano-assemblies in water in comparison to only polymer due to stronger H-bond formation between polymer and TA. Further, due to the spectral overlap between CPT and CUR and a stable, smaller nano-assembly formation by the pro-drug polymer in water in presence of TA, a successful Fluorescence Resonance Energy Transfer (FRET) signal was generated between the conjugated CPT (FRET donor) and conjugated CUR (FRET acceptor). Interestingly, these stable nano-assemblies showed a preferential breakdown and release of CPT in a tumor-relevant redox environment (in the presence of 50 mM glutathione), leading to the disappearance of the FRET signal. These nano-assemblies exhibited a successful cellular uptake by the cancer cells and an enhanced antiproliferative effect in comparison to the individual drugs in cancer cells (AsPC1 and SW480). Such promising in vitro results with a novel redox-responsive, dual-drug conjugated, FRET pair-based nanosized multimodal delivery vector can be highly useful as an advanced theranostic system towards effective cancer treatment.

摘要

在癌症联合治疗中,多模态递送载体用于提高多种抗癌疏水药物的生物利用度。此外,将治疗药物靶向递送至肿瘤部位并同时监测肿瘤部位的药物释放且无正常器官毒性,是一种新兴且有效的癌症治疗策略。然而,缺乏智能纳米递送系统限制了这种治疗策略的应用。为克服这一问题,通过原位两步反应,分别经由酯键和氧化还原敏感的二硫键(-S-S-)将两种疏水荧光抗癌药物姜黄素(CUR)和喜树碱(CPT)与聚乙二醇(PEG)链共轭,成功合成了一种聚乙二醇化双药共轭两亲聚合物(CPT-S-S-PEG-CUR)。与仅聚合物相比,CPT-S-S-PEG-CUR在单宁酸(TA,一种物理交联剂)存在下在水中自发自组装成阴离子型、尺寸相对较小(约100 nm)且稳定的纳米聚集体,这是由于聚合物与TA之间形成了更强的氢键。此外,由于CPT与CUR之间的光谱重叠以及前药聚合物在TA存在下于水中形成稳定、较小的纳米聚集体,在共轭CPT(FRET供体)和共轭CUR(FRET受体)之间产生了成功的荧光共振能量转移(FRET)信号。有趣的是,这些稳定的纳米聚集体在与肿瘤相关的氧化还原环境中(在50 mM谷胱甘肽存在下)显示出CPT的优先分解和释放,导致FRET信号消失。与癌细胞(AsPC1和SW480)中的单个药物相比,这些纳米聚集体在癌细胞中成功实现了细胞摄取并具有增强的抗增殖作用。这种具有新型氧化还原响应性、双药共轭、基于FRET对的纳米级多模态递送载体的体外结果很有前景,可作为一种先进的治疗诊断系统用于有效的癌症治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d4f/10222396/2e1f47d9157b/pharmaceutics-15-01326-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验